An update on emerging anti-amyloid-β monoclonal antibodies for treating Alzheimer's disease: the role of apolipoprotein E

Expert Opin Emerg Drugs. 2025 Jun;30(2):77-81. doi: 10.1080/14728214.2025.2481847. Epub 2025 Mar 26.

Authors

Madia Lozupone¹, Vittorio Dibello², Antonio Daniele^{3

4}, Francesco Panza²

Affiliations

¹ Department of Translational Biomedicine and Neuroscience "DiBraiN", University of Bari Aldo Moro, Bari, Italy.
² Department of Interdisciplinary Medicine, Cesare Frugoni" Internal and Geriatric Medicine and Memory Unit, University of Bari Aldo Moro, Bari, Italy.
³ Department of Neuroscience, Catholic University of Sacred Heart, Rome, Italy.
⁴ Neurology Unit, IRCCS Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.

PMID: 40116132
DOI: 10.1080/14728214.2025.2481847

No abstract available

Keywords: ARIA; Alzheimer’s disease; amyloid-β; apolipoprotein E; cerebrospinal fluid; mild cognitive impairment.

Publication types

Editorial